U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07557537) titled 'A Phase 1 Study of KHN707 Tablets in Healthy Participants' on April 23.
Brief Summary: This is a single-center, randomized, double-blind, placebo-controlled study . The objective is to evaluate the safety , tolerability and PK profile of KHN707 tablets in Chinese healthy participants.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Participants
Intervention:
DRUG: KHN707 tablet
Participants will receive a single dose or two doses of KHN707 tablets orally in a fasting or fed state.
DRUG: Placebo
All participants will receive a single dose or two doses of the placebo in a fasting or fed state....